Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Cumberland Pharmaceuticals (CPIX) Return on Assets (2016 - 2025)

Historic Return on Assets for Cumberland Pharmaceuticals (CPIX) over the last 17 years, with Q3 2025 value amounting to 0.05%.

  • Cumberland Pharmaceuticals' Return on Assets rose 900.0% to 0.05% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.05%, marking a year-over-year increase of 900.0%. This contributed to the annual value of 0.08% for FY2024, which is 100.0% down from last year.
  • Per Cumberland Pharmaceuticals' latest filing, its Return on Assets stood at 0.05% for Q3 2025, which was up 900.0% from 0.04% recorded in Q2 2025.
  • In the past 5 years, Cumberland Pharmaceuticals' Return on Assets ranged from a high of 0.03% in Q1 2021 and a low of 0.14% during Q3 2024
  • Over the past 5 years, Cumberland Pharmaceuticals' median Return on Assets value was 0.0% (recorded in 2023), while the average stood at 0.03%.
  • Its Return on Assets has fluctuated over the past 5 years, first tumbled by -1400bps in 2024, then skyrocketed by 900bps in 2025.
  • Cumberland Pharmaceuticals' Return on Assets (Quarter) stood at 0.02% in 2021, then plummeted by -76bps to 0.01% in 2022, then tumbled by -1460bps to 0.07% in 2023, then decreased by -13bps to 0.08% in 2024, then soared by 41bps to 0.05% in 2025.
  • Its Return on Assets was 0.05% in Q3 2025, compared to 0.04% in Q2 2025 and 0.05% in Q1 2025.